GuideWell opens collaborative ecosystem for health innovation

GuideWell Innovation launched its Collaborative Resource Ecosystem (CoRE) in Orlando’s Lake Nona Medical City, which aims to serve as a network connecting entrepreneurs, research and development experts and healthcare leaders with innovative ideas, funding opportunities and resources in order to develop the next generation of health solutions.

“GuideWell is committed to improving the healthcare system. The collaborative ideas and solutions that will come out of the GuideWell Innovation CoRE will allow us to reshape health, and GuideWell will put its support behind fostering these new solutions,” said Pat Geraghty, Chairman and CEO of GuideWell, in a release. “We also will be working with early-stage health companies and helping incubate those companies while they are developing new technologies and solutions for healthcare.”

The GuideWell Innovation CoRE can be accessed in several ways including direct participation in one of the exclusive immersion events or through a CoRE membership.

“GuideWell Innovation’s mission is to advance the transformation of the health industry by rapidly accelerating health innovation. The CoRE will allow us to bring together start-ups and industry leaders to fast-track health solutions that can radically transform our health system into a more integral and useful part of people’s lives,” said Renee Finely, head of GuideWell Innovation.

The GuideWell Innovation CoRE is anchored in a 30,000-square-foot collaboration space on the first floor of the new GuideWell UST Global Innovation Center facility. The CoRE is designed to become the epicenter of health innovation by offering interactive opportunities for innovators, entrepreneurs and healthcare leaders to work together, and by providing inside-track access to the healthcare system, including the GuideWell family of companies, and expertise on accelerating  development and commercialization of new health solutions and technologies.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.